Global Drugs for Mouth Ulcer Market Report, History and Forecast 2018-2034, Breakdown Data by Manufacturers, Key Regions, Types and Application
Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare
Publisher : MRA | Format : PDF
Global Drugs for Mouth Ulcer Market Report, History and Forecast 2018-2034, Breakdown Data by Manufacturers, Key Regions, Types and Application
Mouth ulcers, also known as canker sores, are normally small, painful lesions that develop in mouth or at the base of gums. They can make eating, drinking, and talking uncomfortable. Mouth ulcers aren’t contagious and usually go away within one to two weeks. Most ulcers will heal completely without any intervention. Treatment can range from simply smoothing or removing a local cause of trauma, to addressing underlying factors such as dry mouth or substituting a problem medication. Maintaining good oral hygiene and use of an antiseptic mouthwash or spray can prevent secondary infection and therefore hasten healing. A topical analgesic may reduce pain. Topical (gels, creams or inhalers) or systemic steroids may be used to reduce inflammation. An antifungal drug may be used to prevent oral candidiasis developing in those who use prolonged steroids In this report, the mouth ulcers treatment drugs include mouthwash, gel, spray, and lozenge. The drug classes in this market are corticosteroid, anesthetic, analgesic, antihistamine, and antimicrobial.
Drugs for Mouth Ulcer report published by QYResearch reveals that COVID-19 and Russia-Ukraine War impacted the market dually in 2022. Global Drugs for Mouth Ulcer market is projected to reach US$ 2100.5 million in 2034, increasing from US$ 1609 million in 2022, with the CAGR of 3.8% during the period of 2024 to 2034. Demand from Hospitals and Clinics are the major drivers for the industry.
Global Mouth Ulcer Treatment Drug key players include Colgate-Palmolive, Pfizer, GlaxoSmithKline, 3M Healthcare, Sannova, etc. Global top five manufacturers hold a share about 40%. North America is the largest market, with a share about 40%, followed by Europe, with a share about 30 percent. In terms of product, Gel is the largest segment, with a share about 65%. And in terms of application, the largest application is Drugstores, followed by Clinics, Hospitals, etc.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Drugs for Mouth Ulcer market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Manufacturers, Type, Application and Regions Listed in the Report

Blistex
Church & Dwight
Novartis Pharmaceuticals
Bausch Health
Pfizer
3M
Colgate-Palmolive
Sinclair Pharma
Blairex Laboratories
Diomed Developments
Dr. Reddy's Laboratories
EPIEN Medical
Henry Schein
Meda Pharmaceuticals
Taro Pharmaceuticals Industries
Segment by Type
Antihistamine
Antibacterial
Corticosteroid and Analgesic
Other
Hospitals
Clinics
Other
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Each chapter of the report provides detailed information for readers to understand the Drugs for Mouth Ulcer market further
Chapter 1Product Definition, Product Types, Volume and Revenue analysis of Each Type in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 2Manufacturer Competition Status, including Sales and Revenue comparison, Manufacturers’ commercial date of Drugs for Mouth Ulcer, product type offered by each manufacturer, Mergers & Acquisitions activities, Expansion activities occurred in the Drugs for Mouth Ulcer industry.
Chapter 3Historical (2018-2022) and forecast (2024-2034) volume and revenue analysis of Drugs for Mouth Ulcer in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa.
Chapter 4Product Application, Volume and Revenue analysis of Each Application in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 5 to 9Country Level analysis of North America, Europe, Asia-Pacific, Latin America, Middle East and Africa, including volume and revenue analysis.
Chapter 10Manufacturers’ Outline, covering company’s basic information like headquarter, contact information, major business, Drugs for Mouth Ulcer introduction, etc. Drugs for Mouth Ulcer Sales, Revenue, Price and Gross Margin of each company as well as Recent Development are also contained in this part.
Chapter 11Industry Chain, like raw materials, manufacturing cost, are covered. In addition, market opportunities and challenges are emphasized as well in the chapter.
Chapter 12Market Channel, Distributors and Customers are listed.
Chapter 13QYResearch’s Conclusions of Drugs for Mouth Ulcer market based on comprehensive survey.
Chapter 14Methodology and Data Sources adopted by QYResearch.
Drugs for Mouth Ulcer report published by QYResearch reveals that COVID-19 and Russia-Ukraine War impacted the market dually in 2022. Global Drugs for Mouth Ulcer market is projected to reach US$ 2100.5 million in 2034, increasing from US$ 1609 million in 2022, with the CAGR of 3.8% during the period of 2024 to 2034. Demand from Hospitals and Clinics are the major drivers for the industry.
Global Mouth Ulcer Treatment Drug key players include Colgate-Palmolive, Pfizer, GlaxoSmithKline, 3M Healthcare, Sannova, etc. Global top five manufacturers hold a share about 40%. North America is the largest market, with a share about 40%, followed by Europe, with a share about 30 percent. In terms of product, Gel is the largest segment, with a share about 65%. And in terms of application, the largest application is Drugstores, followed by Clinics, Hospitals, etc.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Drugs for Mouth Ulcer market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Manufacturers, Type, Application and Regions Listed in the Report

By Company
Blistex
Church & Dwight
Novartis Pharmaceuticals
Bausch Health
Pfizer
3M
Colgate-Palmolive
Sinclair Pharma
Blairex Laboratories
Diomed Developments
Dr. Reddy's Laboratories
EPIEN Medical
Henry Schein
Meda Pharmaceuticals
Taro Pharmaceuticals Industries
Segment by Type
Antihistamine
Antibacterial
Corticosteroid and Analgesic
Other
Segment by Application
Hospitals
Clinics
Other
Segment by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Each chapter of the report provides detailed information for readers to understand the Drugs for Mouth Ulcer market further
Chapter 1Product Definition, Product Types, Volume and Revenue analysis of Each Type in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 2Manufacturer Competition Status, including Sales and Revenue comparison, Manufacturers’ commercial date of Drugs for Mouth Ulcer, product type offered by each manufacturer, Mergers & Acquisitions activities, Expansion activities occurred in the Drugs for Mouth Ulcer industry.
Chapter 3Historical (2018-2022) and forecast (2024-2034) volume and revenue analysis of Drugs for Mouth Ulcer in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa.
Chapter 4Product Application, Volume and Revenue analysis of Each Application in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 5 to 9Country Level analysis of North America, Europe, Asia-Pacific, Latin America, Middle East and Africa, including volume and revenue analysis.
Chapter 10Manufacturers’ Outline, covering company’s basic information like headquarter, contact information, major business, Drugs for Mouth Ulcer introduction, etc. Drugs for Mouth Ulcer Sales, Revenue, Price and Gross Margin of each company as well as Recent Development are also contained in this part.
Chapter 11Industry Chain, like raw materials, manufacturing cost, are covered. In addition, market opportunities and challenges are emphasized as well in the chapter.
Chapter 12Market Channel, Distributors and Customers are listed.
Chapter 13QYResearch’s Conclusions of Drugs for Mouth Ulcer market based on comprehensive survey.
Chapter 14Methodology and Data Sources adopted by QYResearch.
